Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial

Guardado en:
Detalles Bibliográficos
Autores principales: Wouter B Nagengast, J Marc C van Dijk, André P van Beek, Rob A Vergeer, Mark R Postma, Iris Schmidt, Astrid GW Korsten-Meijer, Robert A Feijen, Schelto Kruijff, Wilfred F A den Dunnen, Jos M A Kuijlen, Gerrit van den Berg
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
R
Acceso en línea:https://doaj.org/article/6890a406da9240c0a16543be3043e210
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6890a406da9240c0a16543be3043e210
record_format dspace
spelling oai:doaj.org-article:6890a406da9240c0a16543be3043e2102021-11-24T05:00:07ZDetection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial10.1136/bmjopen-2021-0491092044-6055https://doaj.org/article/6890a406da9240c0a16543be3043e2102021-10-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/10/e049109.fullhttps://doaj.org/toc/2044-6055Wouter B NagengastJ Marc C van DijkAndré P van BeekRob A VergeerMark R PostmaIris SchmidtAstrid GW Korsten-MeijerRobert A FeijenSchelto KruijffWilfred F A den DunnenJos M A KuijlenGerrit van den BergBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Wouter B Nagengast
J Marc C van Dijk
André P van Beek
Rob A Vergeer
Mark R Postma
Iris Schmidt
Astrid GW Korsten-Meijer
Robert A Feijen
Schelto Kruijff
Wilfred F A den Dunnen
Jos M A Kuijlen
Gerrit van den Berg
Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
format article
author Wouter B Nagengast
J Marc C van Dijk
André P van Beek
Rob A Vergeer
Mark R Postma
Iris Schmidt
Astrid GW Korsten-Meijer
Robert A Feijen
Schelto Kruijff
Wilfred F A den Dunnen
Jos M A Kuijlen
Gerrit van den Berg
author_facet Wouter B Nagengast
J Marc C van Dijk
André P van Beek
Rob A Vergeer
Mark R Postma
Iris Schmidt
Astrid GW Korsten-Meijer
Robert A Feijen
Schelto Kruijff
Wilfred F A den Dunnen
Jos M A Kuijlen
Gerrit van den Berg
author_sort Wouter B Nagengast
title Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
title_short Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
title_full Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
title_fullStr Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
title_full_unstemmed Detection by fluorescence of pituitary neuroendocrine tumour (PitNET) tissue during endoscopic transsphenoidal surgery using bevacizumab-800CW (DEPARTURE trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
title_sort detection by fluorescence of pituitary neuroendocrine tumour (pitnet) tissue during endoscopic transsphenoidal surgery using bevacizumab-800cw (departure trial): study protocol for a non-randomised, non-blinded, single centre, feasibility and dose-finding trial
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/6890a406da9240c0a16543be3043e210
work_keys_str_mv AT wouterbnagengast detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT jmarccvandijk detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT andrepvanbeek detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT robavergeer detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT markrpostma detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT irisschmidt detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT astridgwkorstenmeijer detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT robertafeijen detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT scheltokruijff detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT wilfredfadendunnen detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT josmakuijlen detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
AT gerritvandenberg detectionbyfluorescenceofpituitaryneuroendocrinetumourpitnettissueduringendoscopictranssphenoidalsurgeryusingbevacizumab800cwdeparturetrialstudyprotocolforanonrandomisednonblindedsinglecentrefeasibilityanddosefindingtrial
_version_ 1718415917175537664